[Depressive disorders in patients after stroke].
Post-stroke depression is a serious complication of ischemic stroke that exerts a negative effect on patient's quality of life, restoration of symptoms and prognosis. The study of efficacy of the drug opra (citalopram) in the treatment of post-stroke depression revealed the improvement in 93.3% of patients. Along with antidepressant action, opra has a marked anxiolytic effect. The drug does not exert a negative influence on daily activities, cognitive functioning and has minimal side-effects.
Gusev
E I
EI
Bogolepova
A N
AN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015283:Citalopram / Q000009:adverse effects / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000150:complications*; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D015283:Citalopram